Stay updated on Tucatinib Combo for HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo for HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo for HER2+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.3.2 instead of Revision: v3.3.1.
    Difference
    0.1%
    Check dated 2025-12-01T15:11:19.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The latest version history adds revision v3.3.1 and removes v3.2.0 from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:15:39.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Removed the government funding status notice regarding NIH operating status; this administrative notice does not affect trial data or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:12:25.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    - Added a new version entry dated 2025-05-16 to the Record History for NCT04721977, updating the study status and related fields.
    Difference
    0.1%
    Check dated 2025-11-03T00:50:37.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Update includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.
    Difference
    10%
    Check dated 2025-10-05T07:38:21.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.2%
    Check dated 2025-09-28T02:58:50.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo for HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo for HER2+ Breast Cancer Clinical Trial page.